February 2005    Vol. 1 No. 2    CD0486

Protecting Your Investment With Aureo S 700®

As with most investments, the sooner you begin -
the bigger the long-term rewards.
This especially holds true for calves.

The first few weeks in the life of a calf are the most critical
in terms of health protection. The newborn calf enters
a world saturated with pathogens and
little protection against disease organisms.

Timing of treatment is a key factor when using
medicated feed for your calves. The more you know,
the more informed decision you’ll be able to make
to protect your investment.


Treating Early Can Make A Sizable Difference

Even before calves show signs of illness, sub-clinical infections can silently erode gains. Treating calves early, before they become clinically ill, provides antimicrobials to those calves not easily recognizable as sick.
  1. Research shows that Aureo S 700® helps calves fight off important respiratory bacteria.
    • Antimicrobials don’t kill all the targeted bacteria. The calf must eliminate infection on its own, with the aid of a healthy immune system.
    • Thus, any action by antimicrobials that is deleterious to bacteria helps the calf overcome infection.
    • Recent findings show that Aureo S 700 effectively reduces the growth of both Haemophilus somnus and Mannheimia haemolytica,1 helping the calf overcome infection with these two important respiratory bacteria.

  2. Aureo S 700 is even more effective in healthy-appearing calves - so why wait?
    • Research suggests that pretreatment - prior to fever - is more likely to be effective in the treatment or prevention of BRD.1
    • This supports the philosophy that Aureo S 700 should be used early in disease onset when calves are not critically ill.1

  3. Aureo S 700 is proven to reduce lung lesions caused by H. somnus by 88%.2

  4. Only Aureo S 700 contains both Aureomycin® and sulfamethazine in each granule, along with the Aureomycin guarantee.

  5. Aureo S 700 granulation ensures uniform distribution so calves get a full effective dose.
    • Granular formulation flows freely with minimum dust and fines.
    • Feedmill studies show that carry-over risk is reduced by using granular products.3

References

  1. Sub-MIC effects of Aureomycin®, Aureo S 700®, and temperature on growth kinetics and outer membrane protein expression in Mannheimia haemolytica and Haemophilus somnus. 2004. Technical Bulletin No. CD 0467, pp.1-8.
  2. Effects of Aureo S 700® and Aureomycin® in reducing lung lesions in Haemophilus somnus-challenged calves. 2002. Technical Bulletin No. CD 0329, pp. 1-2.
  3. Data on file, Alpharma Animal Health.
AureoS 700® - Get calves off to the right start.

Aureomycin and Aureo S 700 are registered trademarks of Alpharma.

© 2005 Alpharma Inc. All rights reserved.

Alpharma® Animal Health Division

Alpharma Inc.
One Executive Drive
Fort Lee, NJ 07024, USA
Tel: (800) 643-5791
www.alpharma.com

© Copyright 2006 - 2007 Alpharma Inc. all rights reserved
Home | About Us | Cattle News Room | Industry Links | Need Help? | Health Tools | Health Topics | Contact Us | Site Map | Privacy Policy | Trademarks